山梨糖醇 6-磷酸酯 | 20479-58-7

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 山梨糖醇 6-磷酸酯
• 中文别名: 山梨糖醇6-磷酸酯
• 英文名称: Sorbitol 6-phosphate
• 英文别名: D-sorbitol 6-phosphate；Sorbitol-6-phosphate；[(2R,3R,4R,5S)-2,3,4,5,6-pentahydroxyhexyl] dihydrogen phosphate
• CAS: 20479-58-7
• 化学式: C₆H₁₅O₉P
• 分子量: 262.153
• InChiKey: GACTWZZMVMUKNG-SLPGGIOYSA-N

物化性质

• 沸点：
  701.4±70.0 °C(Predicted)
• 密度：
  1.844±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -4.7
• 重原子数：
  16
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  168
• 氢给体数：
  7
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  山梨糖醇 6-磷酸酯 在 apple recombinant N-term tagged aldose-6-phosphate reductase 、 NADPH 作用下， 生成 D-半乳糖-6-磷酸
  参考文献：
  名称：

  Aldose-6-phosphate reductase from apple leaves: Importance of the quaternary structure for enzyme activity

  摘要：

  Aldose-6-phosphate reductase (A6PRase) is a key enzyme for glucitol biosynthesis in plants from the Rosaceae family. To gain on molecular tools for enzymological studies, we developed an accurate system for the heterologous expression of A6PRase from apple leaves. The recombinant enzyme was expressed with a His-tag alternatively placed in the N- or C-terminus, thus allowing the one-step protein purification by immobilized metal affinity chromatography. Both, the N- and the C-term tagged enzymes exhibited similar affinity toward substrates, although the k(cat) of the latter enzyme was 80-fold lower than that having the His-tag in the N-term. Gel filtration chromatography showed different oligomeric structures arranged by the N- (dimer) and the C-term (monomer) tagged enzymes. These results, reinforced by homology modeling studies, point out the relevance of the C-term domain in the structure of A6PRase to conform an enzyme having optimal specific activity and the proper quaternary structure. (C) 2009 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.biochi.2009.09.013
• 作为产物：
  描述：

  D-葡萄糖-6-磷酸 在 sodium tetrahydroborate 作用下， 反应 2.0h， 生成 山梨糖醇 6-磷酸酯
  参考文献：
  名称：

  山梨糖醇，藻酸生物合成中 L-古洛糖醛酸的前体

  摘要：

  摘要 将放射性 D -[U- 14 C] 山梨糖醇 6-磷酸注入幼小生长的马尾藻尖端，在几小时内转化为放射性 L -古洛糖醛酸。AC 5 -差向异构酶可逆地干预以平衡新合成的海藻酸中甘露糖醛酸和古洛糖醛酸的比例。

  DOI：

  10.1016/s0031-9422(00)80804-3

文献信息

• [EN] SULFONYL COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN<br/>[FR] COMPOSÉS DE SULFONYLE QUI INTERAGISSENT AVEC LA PROTÉINE RÉGULATRICE DE LA GLUCOKINASE
  申请人：AMGEN INC

  公开号：WO2013123444A1

  公开（公告）日：2013-08-22

  The present invention relates to sulfonyl compounds that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.

  本发明涉及与葡萄糖激酶调节蛋白相互作用的磺酰基化合物。此外，本发明涉及使用这些化合物或其药学上可接受的盐治疗2型糖尿病和其他涉及葡萄糖激酶调节蛋白的疾病和/或症状的方法，以及含有这些化合物或其药学上可接受的盐的药物组合物。
• Para-aryl or heterocyclic substituted phenyl glucokinase activators
  申请人：——

  公开号：US20020002190A1

  公开（公告）日：2002-01-03

  Para-aryl or heteroaryl substituted phenyl amides which are active as glucokinase activators to increase insulin secretion which makes them useful for treating type II diabetes.

  对于糖激酶激活剂活性的对-芳基或杂芳基取代的苯酰胺，可以增加胰岛素分泌，因此对治疗II型糖尿病有用。
• Heteroaromatic glucokinase activators
  申请人：——

  公开号：US20010039344A1

  公开（公告）日：2001-11-08

  2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 2-position being a substituted phenyl group and at the 3-position being a cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.

  2,3-二取代N-杂环丙酰胺，其中2-位取代为取代苯基，3-位取代为环烷基环，这些丙酰胺是葡萄糖激酶激活剂，可增加胰岛素分泌，用于治疗2型糖尿病。
• AZAINDOLE GLUCOKINASE ACTIVATORS
  申请人：Berthel Steven Joseph

  公开号：US20110144105A1

  公开（公告）日：2011-06-16

  Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.

  提供的化合物为公式(I)： 以及其中可接受的药用盐，其中取代基如说明书所述。这些化合物以及包含它们的药物组合物，可用于治疗代谢性疾病和障碍，例如，2型糖尿病。
• [EN] SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES<br/>[FR] DÉRIVÉS DE SULFONYLPIPÉRAZINE QUI INTERAGISSENT AVEC LA PROTÉINE RÉGULATRICE DE LA GLUCOKINASE POUR LE TRAITEMENT DU DIABÈTE
  申请人：AMGEN INC

  公开号：WO2012027261A1

  公开（公告）日：2012-03-01

  The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.

  本发明涉及与葡萄糖激酶调节蛋白相互作用的化合物I式，或其药用盐，此外，本发明涉及使用这些化合物或其药用盐治疗2型糖尿病和其他涉及葡萄糖激酶调节蛋白的疾病和/或症状的方法，以及含有这些化合物或其药用盐的药物组合物。